Navigate
ims logo
print

Facts Addressing Migraine Market Misperceptions

The purpose of this white paper is to examine the overall migraine market size along with cardiovascular risk in the migraine patient population in the U.S. using health care claims data.

This analysis focuses on commonly held misperceptions regarding:

  • The market size and patient demographics for the acute treatment of migraine in the U.S.
  • The proportion of migraine patients who have risk factors for cardiovascular disease or known cardiovascular conditions
  • Current acute treatment patterns of migraine, specifically in migraine patients with cardiovascular risk factors or conditions
Download the White Paper

To download our white paper Facts Addressing Migraine Market Misperceptions please complete the following form:

 

Required*